Clinical Trials For HIV Drug Of Children Gets The Approval Of FDA

Any drug from the clinical trial enters the market only when it gets the approval of FDA, now it is the turn of Children’s HIV drug to enter the market. With the new HIV drug that has passed the tests of the clinical trials, we can expect to see the future generation free from HIV. The efficiency of the new drug, raltegravir demonstrated positive in treating the children affected by HIV. 

The drug was approved to treat the adults in the year 2007. In the clinical trial conducted with the 96 patients showed positive results after being treated with the raltegravir for 24 weeks. 53 percent of the patients had an undetectable amount of HIV in their blood. The results of the trial stated that the drug has excellent efficiency to treat the children with HIV rather than any other medication available in the market.

Research Studies On Monkeys Raise Hopes For Promising Results In HIV Vaccine

The whole world is waiting for the vaccine to treat life threatening diseases HIV. The researched drugs will be experimented on the animals to test the safety and efficiency of the drug before they are passed to human trials. The new vaccine to treat HIV showed promising results when experimented on the monkeys.  According to the reports stated in the online journal, the research studies conducted by the Harvard Medical School reports that monkeys that received an active drug were less likely get infected from the virus exposed when compared to the monkeys that received placebo. 

The positive results of the research raised hopes for entry of HIV vaccine into the new world. The upcoming of HIV vaccine reached little bit closer as the research produced significant information about the ingredients of the vaccine that will benefit humans. The data from the research trials is quite helpful in conducting the clinical trial and it brings in hope to positive results in HIV vaccine.

The Diabetic Drug Supports Weight Loss

The clinical trials conducted to test the safety and efficiency of the diabetes drugs, glucagon-like peptide-1 receptor (GLP-1R) found it to be effective in providing obese patient weight loss solutions too. The results showed an effective weight loss solution to the patients irrespective of whether they are the sufferers of diabetes.

The clinical trial operated included 6,411 adults. The participants were given at clinically relevant doses for at least 20 weeks. The subjects observed significant weight loss in the clinical trial. Researchers warned that there is still more research has to be carried out on cardiovascular disease comorbidities before it is recommended for weight loss.

Effects Of Placebo Is Very Strong Than Expected

The known fact is that clinical trials are the tests conducted on the drug formulation to decide their efficiency and safety. The hidden truth is that not every volunteer that enters the clinical trial gains accesses the new medication to treat their diseases. Clinical trials are conducted to bring an improved medicine over the standard one. The trail is conducted on the two different groups to know the efficiency of the improved drug over the standard one.One group that receives an experimental drug come under active participants and the ones that receive the standard one fall under placebo. 

Not all the times the pharmaceutical companies look forward to bring the new medicine into the market. They sometimes do it to prevent the flow of the cheaper generic into the market. Clinical trials are always conducted to bring in the improved medicine over the standard one. When the patients see the failure in the new drug developed in the clinical trial, the placebo drug used in the same trial captures the market showing its effectiveness.

Misleading Data in The Clinical Trial is a Costly Mistake

The role of clinical data in the clinical trial process plays important role. The findings of the clinical trial has to be reported on timely basis which otherwise would lead into costly mistake raising the medical expenses of the patients. Most of the physicians and policy makers relay on the peer review publications to study about the clinical trial data, lack of information on the clinical trial would miss-lead the physicians to underestimate the effect of the drug and few estimate identical drug efficacy. You can also see the scenarios where some of the physicians estimate over efficiency of the drug. The unpublished clinical data is misleading the opinions of the physicians and leading into costly medical mistake. Many hurdles like lack of incentive to disseminate negative findings, time constraints, limited resources, changing interests and the article being rejected by the journal. 

One should take an extra effort publish the clinical trial data in order to keep the physicians keep guessing about the efficiency of the drug

Early Stage Clinical Trials Are Running Throughout The World To Bring In Natural Medicine For Cancer

the secret war is being fought for the natural medicines of cancer since many years. the sales for cancer drug trails are expected to hit $80 billion dollar this year. by this one should understand the number of cancer sufferers throughout the year. this has been suppressed by the cash cows for the long period of time. with the raised interest of the people towards the natural medicine to treat cancer, the clinical trials have been initiated with testing green tea, curcumin, iv vitamin c, Chinese herbs, and many other natural medicines against cancer.

Almost 250 clinical trials are on the way to come with the natural medicine of the cancer, let’s hope these trials to succeed and soon the world see the replacement of expensive cancer drug medicines with the natural ones.

Know The Responsibilities Of The Clinical Trial Investigator

Investigator is one of the key personal in the clinical trial process, handling the said responsibilities with due care will contribute the major part in clinical trial success. The investigator should produce appropriate certificates as demanded by the sponsor. He also should be familiar with the instruments and the products used in the clinical trial as prescribed in the protocol. Good practice adherence is one of the main criteria of the clinical trial investigator. The clinical trial investigator should demonstrate the capability to recruit required number of subjects to run the clinical trial successfully. 

The very important function of the investigator in the clinical trial is the medical care that is given to the participants of the clinical trial. The investigator has to conduct the clinical trial in compliance with the IRB approved research application. The investigator should ensure to fallow the randomized clinical trial, if it exists in the clinical trial protocol. He also should ensure that the data is accurately maintained in the reports submitted to the sponsor.

iPhones Help In Patient Recruitment And Retention

iPhoes are playing an active role in the clinical trial progress. They help in increasing accessibility to wide range of the people. Increased accessibility to clinical trial information is increasing the volunteer participation in the clinical trial. Fear about the clinical trial process stand as main block for the volunteers to participate and stay throughout the process. iPhone also helps in retaining the participants throughout the process by demonstrating the actual process of the clinical trial through the video captured in the treatment trials. The investigator takes very less time in explaining the process of the clinical trial because the video is captured through iphone. The participant of the clinical trial better understands the care taken in the clinical trial before their participation in the clinical trial, so the chances of patient retention are high in the clinical trials.

Personalized Medicines Will Be A Breakthrough In The Medical World

People are now tired of spending huge sum of money in getting treated with the same old traditional methods and still not able to find any results from it. Even the effects of the clinical trials will be zero in such scenarios, especially when the medication that is given includes genetic problems. Genes of person varies and responds differently to the same drugs. The patient will benefit more when treatment includes different treatment and drugs customized to what the patient's genes will respond to positively.

Rather than using the old established methods, implementing personalized medicine treatment will benefit the patient and also brings new advancement in the medical history.